JUPW vs. KZR, AVRO, SEPA, VAXX, GMTX, RPHM, CRTX, CLGN, ENZ, and ICCM
Should you be buying Jupiter Wellness stock or one of its competitors? The main competitors of Jupiter Wellness include Kezar Life Sciences (KZR), AVROBIO (AVRO), SEP Acquisition (SEPA), Vaxxinity (VAXX), Gemini Therapeutics (GMTX), Reneo Pharmaceuticals (RPHM), Cortexyme (CRTX), CollPlant Biotechnologies (CLGN), Enzo Biochem (ENZ), and IceCure Medical (ICCM). These companies are all part of the "medical" sector.
Jupiter Wellness (NASDAQ:JUPW) and Kezar Life Sciences (NASDAQ:KZR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability.
Kezar Life Sciences has a net margin of 0.00% compared to Jupiter Wellness' net margin of -210.13%. Kezar Life Sciences' return on equity of -43.08% beat Jupiter Wellness' return on equity.
Kezar Life Sciences received 133 more outperform votes than Jupiter Wellness when rated by MarketBeat users. Likewise, 57.83% of users gave Kezar Life Sciences an outperform vote while only 0.00% of users gave Jupiter Wellness an outperform vote.
Jupiter Wellness has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500. Comparatively, Kezar Life Sciences has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500.
In the previous week, Jupiter Wellness and Jupiter Wellness both had 1 articles in the media. Jupiter Wellness' average media sentiment score of 0.40 beat Kezar Life Sciences' score of -1.00 indicating that Jupiter Wellness is being referred to more favorably in the media.
Kezar Life Sciences has a consensus target price of $11.00, suggesting a potential upside of 1,231.72%. Given Kezar Life Sciences' higher possible upside, analysts clearly believe Kezar Life Sciences is more favorable than Jupiter Wellness.
Jupiter Wellness has higher earnings, but lower revenue than Kezar Life Sciences. Jupiter Wellness is trading at a lower price-to-earnings ratio than Kezar Life Sciences, indicating that it is currently the more affordable of the two stocks.
15.6% of Jupiter Wellness shares are held by institutional investors. Comparatively, 67.9% of Kezar Life Sciences shares are held by institutional investors. 32.9% of Jupiter Wellness shares are held by company insiders. Comparatively, 7.9% of Kezar Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Kezar Life Sciences beats Jupiter Wellness on 12 of the 16 factors compared between the two stocks.
Get Jupiter Wellness News Delivered to You Automatically
Sign up to receive the latest news and ratings for JUPW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JUPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jupiter Wellness Competitors List
Related Companies and Tools
